Extensive clinical research, including the renowned SURMOUNT studies, has shown that Tirzepatide leads to significant weight reduction in individuals with obesity or who are overweight, outperforming many traditional weight loss medications
11 were in the final stages of clinical trials as of June 2024 [112] Among others, Hangzhou Jiuyuan Gene Engineering, The United Laboratories, CSPC Pharmaceutical Group, Huadong Medicine (which also holds a majority stake in Jiuyuan Gene [115] ) and Sihuan Pharmaceutical were all preparing generic offerings
If you are switching from tirzepatide to semaglutide or between different medications entirely, the conversions become even more complex
Even cheaper GLP-1s cost hundreds of dollars monthly
Lock in your weight loss journey with exclusive bundle pricing: 3 Months $680 upfront ($227/mo) Available only to existing Ness patients or those with proof of a previous GLP-1 prescription
Read our full review here: Henry Meds GLP-1 Clinic Review 5
